NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

血液循環動態監控系統的全球市場 - 至2027年的預測

Global Hemodynamic Monitoring System Market Research Report-Forecast till 2027

出版商 Market Research Future 商品編碼 1002679
出版日期 內容資訊 英文 154 Pages
訂單完成後即時交付
價格
血液循環動態監控系統的全球市場 - 至2027年的預測 Global Hemodynamic Monitoring System Market Research Report-Forecast till 2027
出版日期: 2021年02月01日內容資訊: 英文 154 Pages
簡介

市場概要

全球血液循環動態監控系統市場,預計從2020年到2027年的預測期間內以6.48%的年複合成長率成長。重病的老年人增加,及心血管障礙和糖尿病的盛行率上升,家用及非侵入性的監控系統的需求高漲,血液循環動態監控系統的技術性演進等,促進該市場成長。全球血液循環動態監控系統的市場規模,2019年記錄12億6,560萬美元的最高額,預計成為受關注的市場。血液循環動態監控系統,由於微創或非侵入性的產品成長,在居家醫療的現場和診療所的銷售額增加。

本報告提供全球血液循環動態監控系統市場調查,市場概要,各類型、產品、終端用戶、地區的市場規模的變化與預測,市場促進因素及阻礙因素分析,競爭情形,主要企業簡介等彙整資訊。

第1章 摘要整理

第2章 市場簡介

  • 調查範圍
  • 調查目的
  • 市場結構
  • 假設與限制

第3章 調查手法

  • 資料探勘
  • 2次調查
  • 1次調查
  • 主要的受訪者明細
  • 預測手法
  • 市場規模的估計手法
    • Bottom-Up(由下而上)方法
    • Top-Down(由上而下)方法
  • 資料的三角測量
  • 檢驗

第4章 市場動態

  • 概要
  • 促進因素
    • 心血管疾病及文明病的盛行率增加
    • 微創的血液循環動態監控系統的需求高漲
    • 血液循環動態監控系統的技術性進步
    • 提高心血管疾病的認識的有利政府舉措
  • 阻礙因素
    • 血液循環動態監控系統相關的風險
  • 市場機會
    • 血液循環動態監控系統的新興市場企業

第5章 市場要素分析

  • 價值鏈分析
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 競爭企業間的敵對關係
    • 新加入企業的威脅
    • 替代品的威脅
  • 新型冠狀病毒感染疾病(COVID-19)的影響分析
    • 需求與供給分析
    • 主要地區的影響
    • 主要企業的影響

第6章 血液循環動態監控系統市場:各類型

  • 概要
  • 侵入性血液循環動態監控系統
  • 低侵入性血液循環動態監控系統
  • 非侵入性血液循環動態監控系統

第7章 血液循環動態監控系統市場:各產品

  • 概要
  • 血液循環動態監控系統
  • 拋棄式

第8章 血液循環動態監控系統市場:各終端用戶

  • 概要
  • 醫院、診療所
  • 門診病人治療中心
  • 其他

第9章 血液循環動態監控系統市場:各地區

  • 概要
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 中東、非洲
    • 中東
    • 非洲

第10章 競爭情形

  • 概要
  • 競爭基準
  • 其他競爭公司的儀表板
  • 主要的成長策略
  • 主要企業
  • 主要的開發分析
  • 主要的發展與成長策略
    • 產品的銷售/產品的認證
    • 合併、收購
    • 夥伴關係/契約

第11章 企業簡介

  • EDWARDS LIFESCIENCES CORPORATION
  • GETINGE AB
  • BAXTER INTERNATIONAL INC.
  • DRAGERWERK AG & CO. KGAA
  • LIDCO GROUP
  • OSYPKA MEDICAL GMBH
  • DELTEX MEDICAL
  • ICU MEDICAL
  • CNSYSTEMS MEDIZINTECHNIK GMBH
  • NI MEDICAL

第12章 附錄

  • 參考文件
  • 相關報告
目錄

Global Hemodynamic Monitoring System Market Forecast till 2017

Market Overview

Global Hemodynamic Monitoring System Market is anticipated to exhibit a healthy CAGR of 6.48% during the forecast period of 2020 to 2027. The global market is primarily attributed to the rising number of critically ill geriatric cases, increasing prevalence of cardiovascular disorders & diabetes, growing demand for home-based and non-invasive monitoring systems, and technological evolution in the hemodynamic monitoring system.

The global hemodynamic monitoring system is expected to witness a notable market owing to the highest value of USD 1,265.60 Million in 2019. Moreover, many major market players focus more on making these hemodynamic monitoring systems technologically expanded to meet the growing product demand through mergers and acquisitions, and product launches. The growth of technologically advanced minimally invasive or non-invasive products for the hemodynamic monitoring system has raised its sales in-home care settings and clinics.

Market Segmentation

Global Hemodynamic Monitoring System Market has been segmented into Type, Product, and End User.

In terms of type segment, the global market has been classified into invasive, minimally invasive, and non-invasive hemodynamic monitoring systems. The non-invasive hemodynamic monitoring system segment is expected to register the highest CAGR of 7.73% during the forecast period.

By product type, the market has been divided into hemodynamic monitoring systems and disposables.

The disposables segment was valued at USD 786.75 million in 2019. The segment is expected to dominate the market due to the rising demand for disposables used for the diagnosis and treatment of critically ill patients.

Based on the end-user segment, the hemodynamic monitoring system market has been classified into hospitals & clinics, ambulatory care centers, and others. The hospitals and clinics segment is expected to dominate the market owing to the growing number of hospitals and clinics and the rapid adoption of advanced technologies in many clinics.

Regional Analysis

The region-specific analysis of the Global Hemodynamic Monitoring System Market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is likely to lead the market owing to the rising prevalence of cardiovascular diseases & diabetes, product launch, and acquisition in this region.

Europe contributed a substantial share of 29.8% in the global market owing to the companies' organic growth strategies and a well-developed medical industry in the region. Asia-Pacific is expected to register a fastest-growing market owing to the high incidence of cardiovascular diseases, COPD, and diabetes.

The hemodynamic monitoring system market in Middle East & Africa is anticipated to register a limited growth during the forecast period owing to the increasing prevalence of cardiac disorders and diabetes, rising in the number of critically ill geriatric cases, advancements in technology, funding by private players and government bodies, the growing demand for home-based and non-invasive monitoring systems, and the increasing number of people suffering from hypertension.

Major Players

The Prominent players in the global hemodynamic monitoring system market are Edwards Lifesciences Corporation, Getinge AB, Baxter International Inc., Dragerwerk AG & Co. KGaA, LiDCO Group, Osypka Medical GmbH, Deltex Medical, ICU Medical, CNSYSTEMS MEDIZINTECHNIK GMBH, and NI Medical.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY 16
  • 2.2 RESEARCH OBJECTIVE 16
  • 2.3 MARKET STRUCTURE 16
  • 2.4 ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING 18
  • 3.2 SECONDARY RESEARCH 19
  • 3.3 PRIMARY RESEARCH 20
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 21
  • 3.5 FORECASTING TECHNIQUES 21
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
    • 3.6.1 BOTTOM-UP APPROACH 24
    • 3.6.2 TOP-DOWN APPROACH 24
  • 3.7 DATA TRIANGULATION 25
  • 3.8 VALIDATION 25

4 MARKET DYNAMICS

  • 4.1 OVERVIEW 26
  • 4.2 DRIVERS 27
    • 4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE AND LIFESTYLE RELATED DISEASES 27
    • 4.2.2 RISING DEMAND FOR MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM 27
    • 4.2.3 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMICS MONITORING SYSTEM 27
    • 4.2.4 FAVORABLE GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT CARDIOVASCULAR DISEASES 28
  • 4.3 RESTRAINTS 28
    • 4.3.1 RISKS ASSOCIATED WITH HEMODYNAMIC MONITORING SYSTEM 28
  • 4.4 OPPORTUNITY 29
    • 4.4.1 EMERGING MARKET PLAYERS IN THE HEMODYNAMIC MONITORING SYSTEM 29

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS 30
    • 5.1.1 R&D AND DESIGNING 31
    • 5.1.2 MANUFACTURING 31
    • 5.1.3 DISTRIBUTION & SALES 31
    • 5.1.4 POST-SALES MONITORING 31
  • 5.2 PORTER'S FIVE FORCES MODEL 32
    • 5.2.1 BARGAINING POWER OF SUPPLIERS 32
    • 5.2.2 BARGAINING POWER OF BUYERS 33
    • 5.2.3 THREAT OF NEW ENTRANTS 33
    • 5.2.4 THREAT OF SUBSTITUTES 33
    • 5.2.5 INTENSITY OF RIVALRY 33
  • 5.3 COVID-19 IMPACT ANALYSIS 34
    • 5.3.1 DEMAND SUPPLY ANALYSIS 34
    • 5.3.2 IMPACT ON MAJOR REGIONS (AMERICAS, EUROPE, ASIA-PACIFIC, AND THE MIDDLE EAST & AFRICA) 34
    • 5.3.3 IMPACT ON KEY PLAYERS 35

6 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE

  • 6.1 OVERVIEW 36
  • 6.2 INVASIVE HEMODYNAMIC MONITORING SYSTEM 37
  • 6.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM 38
  • 6.4 NON-INVASIVE HEMODYNAMIC MONITORING SYSTEM 38

7 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT

  • 7.1 OVERVIEW 40
  • 7.2 HEMODYNAMIC MONITORING SYSTEMS 41
  • 7.3 DISPOSABLES 42

8 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER

  • 8.1 OVERVIEW 43
  • 8.2 HOSPITALS & CLINICS 44
  • 8.3 AMBULATORY CARE CENTERS 44
  • 8.4 OTHERS 45

9 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION

  • 9.1 OVERVIEW 46
  • 9.2 AMERICAS 48
    • 9.2.1 NORTH AMERICA 50
      • 9.2.1.1 US 52
      • 9.2.1.2 CANADA 54
    • 9.2.2 LATIN AMERICA 56
  • 9.3 EUROPE 58
    • 9.3.1 WESTERN EUROPE 60
      • 9.3.1.1 GERMANY 62
      • 9.3.1.2 FRANCE 64
      • 9.3.1.3 UK 66
      • 9.3.1.4 ITALY 67
      • 9.3.1.5 SPAIN 69
      • 9.3.1.6 REST OF WESTERN EUROPE 71
    • 9.3.2 EASTERN EUROPE 72
  • 9.4 ASIA-PACIFIC 75
    • 9.4.1 JAPAN 78
    • 9.4.2 CHINA 79
    • 9.4.3 INDIA 81
    • 9.4.4 AUSTRALIA 83
    • 9.4.5 SOUTH KOREA 84
    • 9.4.6 REST OF ASIA-PACIFIC 86
  • 9.5 MIDDLE EAST & AFRICA 88
    • 9.5.1 MIDDLE EAST 90
    • 9.5.2 AFRICA 92

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW 94
  • 10.2 COMPETITIVE BENCHMARKING 96
  • 10.3 COMPETITOR DASHBOARD 97
  • 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 98
  • 10.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 99
  • 10.6 KEY DEVELOPMENT ANALYSIS 99
  • 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES 100
    • 10.7.1 PRODUCT LAUNCH/PRODUCT APPROVAL 100
    • 10.7.2 MERGERS/ACQUISITIONS 101
    • 10.7.3 PARTNERSHIPS/AGREEMENTS 102

11 COMPANY PROFILES

  • 11.1 EDWARDS LIFESCIENCES CORPORATION 103
    • 11.1.1 COMPANY OVERVIEW 103
    • 11.1.2 FINANCIAL OVERVIEW 104
    • 11.1.3 PRODUCTS/SERVICES OFFERED 104
    • 11.1.4 KEY DEVELOPMENTS 105
    • 11.1.5 SWOT ANALYSIS 106
    • 11.1.6 KEY STRATEGIES 107
  • 11.2 GETINGE AB 108
    • 11.2.1 COMPANY OVERVIEW 108
    • 11.2.2 FINANCIAL OVERVIEW 108
    • 11.2.3 PRODUCTS/SERVICES OFFERED 109
    • 11.2.4 KEY DEVELOPMENTS 109
    • 11.2.5 SWOT ANALYSIS 110
    • 11.2.6 KEY STRATEGIES 110
  • 11.3 BAXTER INTERNATIONAL INC. 111
    • 11.3.1 COMPANY OVERVIEW 111
    • 11.3.2 FINANCIAL OVERVIEW 111
    • 11.3.3 PRODUCTS/SERVICES OFFERED 112
    • 11.3.4 KEY DEVELOPMENTS 112
    • 11.3.5 SWOT ANALYSIS 113
    • 11.3.6 KEY STRATEGIES 113
  • 11.4 DRAGERWERK AG & CO. KGAA 114
    • 11.4.1 COMPANY OVERVIEW 114
    • 11.4.2 FINANCIAL OVERVIEW 114
    • 11.4.3 PRODUCTS/SERVICES OFFERED 115
    • 11.4.4 KEY DEVELOPMENTS 115
    • 11.4.5 SWOT ANALYSIS 116
    • 11.4.6 KEY STRATEGIES 116
  • 11.5 LIDCO GROUP 117
    • 11.5.1 COMPANY OVERVIEW 117
    • 11.5.2 FINANCIAL OVERVIEW 117
    • 11.5.3 PRODUCTS/SERVICES OFFERED 118
    • 11.5.4 KEY DEVELOPMENTS 118
    • 11.5.5 SWOT ANALYSIS 119
    • 11.5.6 KEY STRATEGIES 119
  • 11.6 OSYPKA MEDICAL GMBH 120
    • 11.6.1 COMPANY OVERVIEW 120
    • 11.6.2 FINANCIAL OVERVIEW 120
    • 11.6.3 PRODUCTS/SERVICES OFFERED 120
    • 11.6.4 KEY DEVELOPMENTS 120
    • 11.6.5 SWOT ANALYSIS 121
    • 11.6.6 KEY STRATEGIES 121
  • 11.7 DELTEX MEDICAL 122
    • 11.7.1 COMPANY OVERVIEW 122
    • 11.7.2 FINANCIAL OVERVIEW 122
    • 11.7.3 PRODUCTS/SERVICES OFFERED 122
    • 11.7.4 KEY DEVELOPMENTS 123
    • 11.7.5 SWOT ANALYSIS 124
    • 11.7.6 KEY STRATEGIES 124
  • 11.8 ICU MEDICAL 125
    • 11.8.1 COMPANY OVERVIEW 125
    • 11.8.2 FINANCIAL OVERVIEW 125
    • 11.8.3 PRODUCTS/SERVICES OFFERED 126
    • 11.8.4 KEY DEVELOPMENTS 126
    • 11.8.5 SWOT ANALYSIS 126
    • 11.8.6 KEY STRATEGIES 126
  • 11.9 CNSYSTEMS MEDIZINTECHNIK GMBH 127
    • 11.9.1 COMPANY OVERVIEW 127
    • 11.9.2 FINANCIAL OVERVIEW 127
    • 11.9.3 PRODUCTS/SERVICES OFFERED 127
    • 11.9.4 KEY DEVELOPMENTS 127
    • 11.9.5 SWOT ANALYSIS 128
    • 11.9.6 KEY STRATEGIES 128
  • 11.10 NI MEDICAL 129
    • 11.10.1 COMPANY OVERVIEW 129
    • 11.10.2 FINANCIAL OVERVIEW 129
    • 11.10.3 PRODUCTS/SERVICES OFFERED 129
    • 11.10.4 KEY DEVELOPMENTS 129
    • 11.10.5 SWOT ANALYSIS 130
    • 11.10.6 KEY STRATEGIES 130

12 APPENDIX

  • 12.1 REFERENCES 131
  • 12.2 RELATED REPORTS 131

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 17
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 20
  • TABLE 3 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 37
  • TABLE 4 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR INVASIVE HEMODYNAMIC MONITORING SYSTEM, BY REGION, 2017-2027 (USD MILLION) 37
  • TABLE 5 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEM, BY REGION, 2017-2027 (USD MILLION) 38
  • TABLE 6 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR NON-INVASIVE HEMODYNAMIC MONITORING SYSTEM, BY REGION, 2017-2027 (USD MILLION) 39
  • TABLE 7 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT, 2017-2027 (USD MILLION) 40
  • TABLE 8 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY REGION, 2017-2027 (USD MILLION) 41
  • TABLE 9 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE, 2017-2027 (USD MILLION) 41
  • TABLE 10 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY REGION, 2017-2027 (USD MILLION) 42
  • TABLE 11 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE, 2017-2027 (USD MILLION) 42
  • TABLE 12 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 43
  • TABLE 13 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2017-2027 (USD MILLION) 44
  • TABLE 14 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2017-2027 (USD MILLION) 45
  • TABLE 15 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2017-2027 (USD MILLION) 45
  • TABLE 16 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2017-2027 (USD MILLION) 47
  • TABLE 17 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2017-2027 (USD MILLION) 48
  • TABLE 18 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 49
  • TABLE 19 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 49
  • TABLE 20 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 49
  • TABLE 21 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 50
  • TABLE 22 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 50
  • TABLE 23 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 50
  • TABLE 24 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 51
  • TABLE 25 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 51
  • TABLE 26 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 51
  • TABLE 27 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 52
  • TABLE 28 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 52
  • TABLE 29 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 52
  • TABLE 30 US: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 53
  • TABLE 31 US: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 53
  • TABLE 32 US: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 53
  • TABLE 33 US: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 54
  • TABLE 34 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 54
  • TABLE 35 CANADA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 54
  • TABLE 36 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 55
  • TABLE 37 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 55
  • TABLE 38 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 55
  • TABLE 39 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 56
  • TABLE 40 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 56
  • TABLE 41 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 56
  • TABLE 42 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 57
  • TABLE 43 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 57
  • TABLE 44 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2017-2027 (USD MILLION) 58
  • TABLE 45 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 58
  • TABLE 46 EUROPE: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 58
  • TABLE 47 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 59
  • TABLE 48 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 59
  • TABLE 49 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 59
  • TABLE 50 WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 60
  • TABLE 51 WETERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 61
  • TABLE 52 WETERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 61
  • TABLE 53 WETERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 61
  • TABLE 54 WETERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 62
  • TABLE 55 WETERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 62
  • TABLE 56 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 62
  • TABLE 57 GERMANY: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 63
  • TABLE 58 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 63
  • TABLE 59 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 63
  • TABLE 60 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 64
  • TABLE 61 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 64
  • TABLE 62 FRANCE: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 64
  • TABLE 63 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 65
  • TABLE 64 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 65
  • TABLE 65 FRANCE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 65
  • TABLE 66 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 66
  • TABLE 67 UK: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 66
  • TABLE 68 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 66
  • TABLE 69 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 67
  • TABLE 70 UK: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 67
  • TABLE 71 ITALY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 67
  • TABLE 72 ITALY: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 68
  • TABLE 73 ITALY: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 68
  • TABLE 74 ITALY: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 68
  • TABLE 75 ITALY: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 69
  • TABLE 76 SPAIN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 69
  • TABLE 77 SPAIN: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 69
  • TABLE 78 SPAIN: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 70
  • TABLE 79 SPAIN: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 70
  • TABLE 80 SPAIN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 70
  • TABLE 81 REST OF WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 71
  • TABLE 82 REST OF WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 71
  • TABLE 83 REST OF WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 71
  • TABLE 84 REST OF WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 72
  • TABLE 85 REST OF WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 72
  • TABLE 86 EASTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 72
  • TABLE 87 EASTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 73
  • TABLE 88 EASTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 73
  • TABLE 89 EASTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 73
  • TABLE 90 EASTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 74
  • TABLE 91 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 75
  • TABLE 92 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 76
  • TABLE 93 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 76
  • TABLE 94 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 77
  • TABLE 95 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 77
  • TABLE 96 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 77
  • TABLE 97 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 78
  • TABLE 98 JAPAN: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 78
  • TABLE 99 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 78
  • TABLE 100 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 79
  • TABLE 101 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 79
  • TABLE 102 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 79
  • TABLE 103 CHINA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 80
  • TABLE 104 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 80
  • TABLE 105 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 80
  • TABLE 106 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 81
  • TABLE 107 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 81
  • TABLE 108 INDIA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 81
  • TABLE 109 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 82
  • TABLE 110 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 82
  • TABLE 111 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 82
  • TABLE 112 AUSTRALIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 83
  • TABLE 113 AUSTRALIA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 83
  • TABLE 114 AUSTRALIA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 83
  • TABLE 115 AUSTRALIA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 84
  • TABLE 116 AUSTRALIA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 84
  • TABLE 117 SOUTH KOREA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 84
  • TABLE 118 SOUTH KOREA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 85
  • TABLE 119 SOUTH KOREA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 85
  • TABLE 120 SOUTH KOREA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 85
  • TABLE 121 SOUTH KOREA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 86
  • TABLE 122 REST OF ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 86
  • TABLE 123 REST OF ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 86
  • TABLE 124 REST OF ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 87
  • TABLE 125 REST OF ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 87
  • TABLE 126 REST OF ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 87
  • TABLE 127 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2017-2027 (USD MILLION) 88
  • TABLE 128 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 89
  • TABLE 129 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 89
  • TABLE 130 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 89
  • TABLE 131 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 90
  • TABLE 132 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 90
  • TABLE 133 MIDDLE EAST: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 90
  • TABLE 134 MIDDLE EAST: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 91
  • TABLE 135 MIDDLE EAST: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 91
  • TABLE 136 MIDDLE EAST: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 91
  • TABLE 137 MIDDLE EAST: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 92
  • TABLE 138 AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2017-2027 (USD MILLION) 92
  • TABLE 139 AFRICA: HEMODYNAMIC MONITORING SYSTEMS, BY PRODUCT, 2017-2027 (USD MILLION) 92
  • TABLE 140 AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR HEMODYNAMIC MONITORING SYSTEMS, BY TYPE 2017-2027 (USD MILLION) 93
  • TABLE 141 AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET FOR DISPOSABLES, BY TYPE 2017-2027 (USD MILLION) 93
  • TABLE 142 AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER, 2017-2027 (USD MILLION) 93
  • TABLE 143 COMPETITOR DASHBOARD: GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 97
  • TABLE 144 MOST ACTIVE PLAYER IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 99
  • TABLE 145 PRODUCT LAUNCH/PRODUCT APPROVAL 100
  • TABLE 146 MERGERS/ACQUISITIONS 101
  • TABLE 147 PARTNERSHIPS/AGREEMENTS 102
  • TABLE 148 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS/SERVICES OFFERED 104
  • TABLE 149 EDWARDS LIFESCIENCES CORPORATION: KEY DEVELOPMENTS 105
  • TABLE 150 GETINGE AB: PRODUCTS/SERVICES OFFERED 109
  • TABLE 151 GETINGE AB: KEY DEVELOPMENTS 109
  • TABLE 152 BAXTER INTERNATIONAL INC.: PRODUCTS/SERVICES OFFERED 112
  • TABLE 153 BAXTER INTERNATIONAL INC.: KEY DEVELOPMENTS 112
  • TABLE 154 DRAGERWERK AG & CO. KGAA: PRODUCTS/SERVICES OFFERED 115
  • TABLE 155 DRAGERWERK AG & CO. KGAA: KEY DEVELOPMENTS 115
  • TABLE 156 LIDCO GROUP: PRODUCTS/SERVICES OFFERED 118
  • TABLE 157 LIDCO GROUP: KEY DEVELOPMENTS 118
  • TABLE 158 OSYPKA MEDICAL GMBH: PRODUCTS/SERVICES OFFERED 120
  • TABLE 159 DELTEX MEDICAL: PRODUCTS/SERVICES OFFERED 122
  • TABLE 160 DELTEX MEDICAL: KEY DEVELOPMENTS 123
  • TABLE 161 ICU MEDICAL: PRODUCTS/SERVICES OFFERED 126
  • TABLE 162 CNSYSTEMS MEDIZINTECHNIK GMBH: PRODUCTS/SERVICES OFFERED 127
  • TABLE 163 NI MEDICAL: PRODUCTS/SERVICES OFFERED 129

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 15
  • FIGURE 2 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET STRUCTURE 16
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 23
  • FIGURE 4 MARKET DYNAMICS: HEMODYNAMIC MONITORING SYSTEM MARKET 26
  • FIGURE 5 DRIVERS: IMPACT ANALYSIS 28
  • FIGURE 6 RESTRAINTS: IMPACT ANALYSIS 29
  • FIGURE 7 VALUE CHAIN: HEMODYNAMIC MONITORING SYSTEM MARKET 30
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: HEMODYNAMIC MONITORING SYSTEM MARKET 32
  • FIGURE 9 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2019 & 2027 (USD MILLION) 36
  • FIGURE 10 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, PRODUCT, 2019 & 2027 (USD MILLION) 40
  • FIGURE 11 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, END USER, 2019 & 2027 (USD MILLION) 43
  • FIGURE 12 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION 2019 & 2027 (USD MILLION) 46
  • FIGURE 13 GLOBAL: HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE, BY REGION 2019 (%) 47
  • FIGURE 14 AMERICAS: HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE, BY REGION 2019 (%) 48
  • FIGURE 15 WESTERN EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE, BY COUNTRY 2019 (%) 60
  • FIGURE 16 ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE, BY COUNTRY 2019 (%) 76
  • FIGURE 17 MIDDLE EAST & AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SHARE, BY REGION 2019 (%) 88
  • FIGURE 18 MAJOR MANUFACTURERS IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 95
  • FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 96
  • FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 98
  • FIGURE 21 GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET: COMPETITIVE LANDSCAPE 99
  • FIGURE 22 EDWARDS LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 104
  • FIGURE 23 EDWARDS LIFESCIENCES CORPORATION: SWOT ANALYSIS 106
  • FIGURE 24 GETINGE AB: FINANCIAL OVERVIEW SNAPSHOT 108
  • FIGURE 25 GETINGE AB: SWOT ANALYSIS 110
  • FIGURE 26 BAXTER INTERNATIONAL INC.: FINANCIAL OVERVIEW SNAPSHOT 111
  • FIGURE 27 BAXTER INTERNATIONAL INC.: SWOT ANALYSIS 113
  • FIGURE 28 DRAGERWERK AG & CO. KGAA: FINANCIAL OVERVIEW SNAPSHOT 114
  • FIGURE 29 DRAGERWERK AG & CO. KGAA: SWOT ANALYSIS 116
  • FIGURE 30 LIDCO GROUP: FINANCIAL OVERVIEW SNAPSHOT 117
  • FIGURE 31 LIDCO GROUP: SWOT ANALYSIS 119
  • FIGURE 32 OSYPKA MEDICAL GMBH: SWOT ANALYSIS 121
  • FIGURE 33 DELTEX MEDICAL: FINANCIAL OVERVIEW SNAPSHOT 122
  • FIGURE 34 DELTEX MEDICAL: SWOT ANALYSIS 124
  • FIGURE 35 ICU MEDICAL: FINANCIAL OVERVIEW SNAPSHOT 125
  • FIGURE 36 ICU MEDICAL: SWOT ANALYSIS 126
  • FIGURE 37 CNSYSTEMS MEDIZINTECHNIK GMBH: SWOT ANALYSIS 128
  • FIGURE 38 NI MEDICAL: SWOT ANALYSIS 130